These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Changes in sexual behavior during a safety and feasibility trial of a microbicide/diaphragm combination: an integrated qualitative and quantitative analysis. Guest G, Johnson L, Burke H, Rain-Taljaard R, Severy L, von Mollendorf C, Van Damme L. AIDS Educ Prev; 2007 Aug; 19(4):310-20. PubMed ID: 17685844 [Abstract] [Full Text] [Related]
24. Vaginal microbicides. O'Brien RF. Adolesc Med Clin; 2006 Oct; 17(3):673-85; abstract xi. PubMed ID: 17030285 [Abstract] [Full Text] [Related]
25. First real success for anti-HIV gel: a new start for HIV microbicides? Ariën KK, Vanham G. Future Microbiol; 2010 Nov; 5(11):1621-3. PubMed ID: 21133683 [No Abstract] [Full Text] [Related]
26. Inhibiting sexual transmission of HIV-1 infection. Shattock RJ, Moore JP. Nat Rev Microbiol; 2003 Oct; 1(1):25-34. PubMed ID: 15040177 [Abstract] [Full Text] [Related]
27. Differentiating normal from abnormal rates of genital epithelial findings in vaginal microbicide trials. van de Wijgert JH, Kilmarx PH, Jones HE, Karon JM, Chaikummao S. Contraception; 2008 Feb; 77(2):122-9. PubMed ID: 18226677 [Abstract] [Full Text] [Related]
29. Microbicides: a new approach to preventing HIV and other sexually transmitted infections. Stone A. Nat Rev Drug Discov; 2002 Dec; 1(12):977-85. PubMed ID: 12461519 [Abstract] [Full Text] [Related]
30. Microbicides and other topical agents in the prevention of HIV and sexually transmitted infections. Nikolic DS, Garcia E, Piguet V. Expert Rev Anti Infect Ther; 2007 Feb; 5(1):77-88. PubMed ID: 17266456 [Abstract] [Full Text] [Related]
31. African trial of HIV drug disappoints. AIDS Read; 2008 Apr; 18(4):166. PubMed ID: 18467998 [No Abstract] [Full Text] [Related]
32. Combining prevention of HIV-1, other sexually transmitted infections and unintended pregnancies: Development of dual-protection technologies. Friend DR, Doncel GF. Antiviral Res; 2010 Dec; 88 Suppl 1():S47-54. PubMed ID: 21109068 [Abstract] [Full Text] [Related]
33. Trials of two microbicides to be launched in Africa. Pincock S. BMJ; 2004 Apr 03; 328(7443):786. PubMed ID: 15070623 [No Abstract] [Full Text] [Related]
34. Recent advances on anti-HIV vaginal delivery systems development. Antimisiaris SG, Mourtas S. Adv Drug Deliv Rev; 2015 Sep 15; 92():123-45. PubMed ID: 25858666 [Abstract] [Full Text] [Related]
35. The epidemiology of new HIV infections and interventions to limit HIV transmission. Buchbinder S. Top HIV Med; 2009 Sep 15; 17(2):37-43. PubMed ID: 19401606 [Abstract] [Full Text] [Related]
36. Vaginal microbicides to prevent human immunodeficiency virus infection in women: perspectives on the female genital tract, sexual maturity and mucosal inflammation. Roberts L, Liebenberg L, Barnabas S, Passmore JA. Best Pract Res Clin Obstet Gynaecol; 2012 Aug 15; 26(4):441-9. PubMed ID: 22429786 [Abstract] [Full Text] [Related]
37. Will vaginal microbicides solve the HIV problem in Africa? Muula AS. Croat Med J; 2006 Dec 15; 47(6):895-8. PubMed ID: 17167863 [No Abstract] [Full Text] [Related]
38. Should microbicides be controlled by women or by physicians? Piret J, Bergeron MG. Int J Infect Dis; 2010 Sep 15; 14 Suppl 3():e14-7. PubMed ID: 20932483 [Abstract] [Full Text] [Related]
39. Microbicide preference among young women in California. Holt BY, Morwitz VG, Ngo L, Harrison PF, Whaley KJ, Pettifor A, Nguyen AH. J Womens Health (Larchmt); 2006 Apr 15; 15(3):281-94. PubMed ID: 16620187 [Abstract] [Full Text] [Related]
40. PRO-2000, an antimicrobial gel for the potential prevention of HIV infection. Fletcher PS, Shattock RJ. Curr Opin Investig Drugs; 2008 Feb 15; 9(2):189-200. PubMed ID: 18246522 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]